Landscape Capital Management’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Landscape Capital Management’s Portfolio MTACU Stock Details MTACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-22,401	Closed	-$225K	–	1029
2021 Q4	$225K	Hold	22,401	–	–	0.03%	462
2021 Q3	$227K	Buy	22,401 +300	+1%	+$3.02K	0.03%	450
2021 Q2	$221K	Buy	+22,101	New	+$223K	0.03%	421

Other funds holding MTACU

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

ICMH

Integrity Capital Management (HK) Central, Hong Kong $64K AUM

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Landscape Capital Management's MTACU Position: Q1 2022 in Review

Landscape Capital Management sold out of MedTech Acquisition Corporation Unit (MTACU) in Q1 2022, closing a stake of 22,401 shares — an estimated $225K sold.

Landscape Capital Management first reported a position in MTACU in Q2 2021 and held it in 3 quarters. The position peaked at $227K in Q3 2021. 5 funds tracked by Wall St. Rank hold MTACU as of Q1 2022.

Landscape Capital Management reported no remaining MedTech Acquisition Corporation Unit position as of Q1 2022 after selling out during the quarter.
Landscape Capital Management sold 22,401 MedTech Acquisition Corporation Unit shares in Q1 2022, an estimated $225K.
Landscape Capital Management first reported a position in MedTech Acquisition Corporation Unit in Q2 2021 and held it in 3 quarters.
Landscape Capital Management's MedTech Acquisition Corporation Unit position peaked at $227K in Q3 2021.
5 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q1 2022.

Based on Landscape Capital Management's 13F filing for Q1 2022, filed 11 May 2022.